Medifast, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 20.60 M

Medifast, Inc. Operating Cash Flow is USD 20.60 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -77.33% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Medifast, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 90.88 M, a -57.72% change year over year.
  • Medifast, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 214.96 M, a 194.90% change year over year.
  • Medifast, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 72.89 M, a -60.34% change year over year.
  • Medifast, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 183.79 M, a 134.84% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities